Explorer les evidences

69,6 %Preoperative antibiotic use for caesarean section patients was 69.6% in 2021.

Sierra Leonesurgical site infectionsobservé 2021publié 2023Tropical medicine and infectious diseaseeurope_pmcdocument de 5 observationsDOI 10.3390/tropicalmed8080385

55 testsMean quarterly HBV tests were 55 ± 6 during January–March in Freetown, Sierra Leone.

Sierra Leonehépatite Bobservé January-Marchpublié 2023Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Phaeurope_pmcdocument de 8 observationsDOI 10.1101/2023.05.24.23290418

23,8 %Surgical prophylaxis was the second most common indication for antibiotic use, accounting for 23.8% of cases.

Sierra Leonesurgical prophylaxispublié 2023BMJ openeurope_pmcdocument de 14 observationsDOI 10.1136/bmjopen-2023-078367

288 sequencing_reagents288 sequencing reagents were delivered to Sierra Leone for Mpox diagnostics.

Sierra LeonempoxAfrica CDCdocument de 72 observations

26 %The likelihood of a positive HIV test was 26% lower in 2020 than in 2019 (prevalence ratio 0.74).

Sierra LeoneVIH/sidaobservé 2020publié 2024AIDS and behavioreurope_pmcdocument de 7 observations

52,2 %Among 306 adult participants in Freetown, Sierra Leone, 52.2% had comprehensive HBV knowledge.

Sierra Leonehépatite Bpublié 2022Assessment of Knowledge, Stigmatizing Attitudes and Health-Seeking Behaviors Regarding Hepeurope_pmcdocument de 3 observationsDOI 10.20944/preprints202211.0233.v1

62,5 %Among eight participants with positive blood CrAg, cerebrospinal fluid CrAg was positive in five, representing 62.5%.

Sierra Leoneméningite cryptococciquepublié 2020BMC infectious diseaseseurope_pmcdocument de 7 observationsDOI 10.1186/s12879-020-4862-x

10 districtsLassa fever cases were observed in ten of Sierra Leone's thirteen districts.

Sierra Leonefièvre de Lassapublié 2014PLoS neglected tropical diseaseseurope_pmcdocument de 6 observations

8,2 %Enterococcus faecalis accounted for 8.2% of 49 bacterial isolates from surgical site infections.

Sierra Leonesurgical site infectionobservé February and July 2021publié 2022Antimicrobial resistance and infection controleurope_pmcdocument de 15 observationsDOI 10.1186/s13756-022-01078-y

35,6 %In 2021, fewer people were tested for HIV than in 2019, representing a reduction of 35.6%.

Sierra LeoneVIH/sidaobservé 2021publié 2024AIDS and behavioreurope_pmcdocument de 7 observations

39,3 %The prevalence of advanced HIV was 39.3% among inpatients aged 15 to 24 years with HIV at a major hospital in Sierra Leone between September 2022 and March 2023.

Sierra LeoneVIH avancéobservé September 2022 to March 2023publié 2023Prevalence and factors associated with advanced HIV disease among young people aged 15 - 2europe_pmcdocument de 8 observationsDOI 10.1101/2023.11.07.23296880

9,34 aORRenal impairment was associated with proteinuria among people living with HIV, with an adjusted odds ratio of 9.34.

Sierra Leoneproteinuria · renal impairmentpublié 2022Journal of clinical medicineeurope_pmcdocument de 9 observations

16,1 %The prevalence of left ventricular hypertrophy (LVH) by electrocardiogram (ECG) among adults in Freetown, Sierra Leone was 16.1%.

Sierra Leoneleft ventricular hypertrophyobservé 2019–2021publié 2023Burden of cardiometabolic risk factors and preclinical target organ damage among adults ineurope_pmcdocument de 8 observationsDOI 10.1101/2023.02.20.23286145

11,8 %Among pregnant women in Sierra Leone, M184V was found in 11.8% (n = 4/34) of cases.

Sierra LeoneVIH/sidapublié 2021Geneseurope_pmcdocument de 21 observationsDOI 10.3390/genes12091314

76,6 %Among children and adolescents in Sierra Leone, the most common HIV drug resistance-associated mutation was M184V, found in 76.6% (n = 49/64) of cases.

Sierra LeoneVIH/sidapublié 2021Geneseurope_pmcdocument de 21 observationsDOI 10.3390/genes12091314

Sierra Leone reported its first mpox case in 8 years in January 2025.

Sierra Leonempoxobservé January 2025publié 2026Nature medicineeurope_pmcdocument de 4 observations

Sierra Leone, Liberia, and Guinea are hyperendemic West African countries for hepatitis B virus.

Guinée · Liberia · Sierra Leonehépatite Bpublié 2023Epidemiology and infectioneurope_pmcdocument de 3 observationsDOI 10.1017/s0950268823001735

24,5 %Serum lactate was elevated in 24.5% of the articles on COVID-19 patients with sepsis or septic shock.

Sierra LeoneCOVID-19 · sepsis · septic shockpublié 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument de 17 observationsDOI 10.21203/rs.3.rs-30474/v1

92 patientsOf 701 drug-resistant TB patients, 92 (12.8%) were registered in the post-COVID-19 period.

Sierra Leonedrug-resistant TBobservé post-COVID-19publié 2025Effect of the COVID-19 pandemic on drug-resistant tuberculosis treatment outcomes at a nateurope_pmcdocument de 9 observations

45,3 %Among children and adolescents in Sierra Leone, K103N was found in 45.3% (n = 29/64) of cases.

Sierra LeoneVIH/sidapublié 2021Geneseurope_pmcdocument de 21 observationsDOI 10.3390/genes12091314

66 %Weakness was present in 66% of patients with Ebola virus disease at presentation.

Sierra Leonemaladie à virus Ebolapublié 2014The New England journal of medicineeurope_pmcdocument de 14 observations

81,3 %Mechanical ventilation was documented in 81.3% of the articles on COVID-19 patients with sepsis or septic shock.

Sierra LeoneCOVID-19 · sepsis · septic shockpublié 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument de 17 observationsDOI 10.21203/rs.3.rs-30474/v1

20,8 %Among 197 patients with chronic respiratory symptoms in an urban tertiary hospital in Sierra Leone, 41 (20.8%) were seropositive for Aspergillus.

Sierra LeoneAspergillusobservé November 2021 to July 2022publié 2023PLoS neglected tropical diseaseseurope_pmcdocument de 9 observations

The analysis used national survey data from 2018 to 2020 of children aged 4–35 months to assess complete hepatitis B virus vaccination.

Sierra Leonehépatite Bobservé 2018-2020publié 2023Epidemiology and infectioneurope_pmcdocument de 3 observationsDOI 10.1017/s0950268823001735

Poor adherence was significantly associated with virologic failure (p = 0.001).

Sierra LeoneVIH/sidaobservé 2019-2020publié 2021Global health actioneurope_pmcdocument de 4 observationsDOI 10.1080/16549716.2021.1947566